Cellectis SA (CLLS) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

CLLS is expected to report earnings to fall 23.93% to -21 cents per share on November 06

Cellectis SA CLLS Stock Earnings Reports

Q3'24

Est.

$-0.21

Q2'24

Beat

by $0.01

Q1'24

Beat

by $0.41

Q4'23

Missed

by $0.43

Q3'23

Missed

by $0.16

The last earnings report on August 06 showed earnings per share of -28 cents, beating the estimate of -28 cents. With 12.63K shares outstanding, the current market capitalization sits at 218.60M.

View a ticker or compare two or three

Compare

CLLS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CLLS
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a genome engineering company of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

8, rue de la Croix Jarry

Phone

+33 181691600

Employees

285

Web

https://www.cellectis.com